Dr. Neil Shah CML Chronic Myeloid Leukemia
Dr. Neil Shah is an Assistant Professor, Division of Hematology/Oncology, University of California, San Francisco (UCSF) School of Medicine
Extract of http://cancer.ucsf.edu/people/shah_neil.php
Extract of http://cancer.ucsf.edu/people/shah_neil.php
VIDEOS
CML Horizons 2014: Outlook - the future of CML therapy (Neil Shah)
May 20, 2014, cmladvocates
Understanding Molecular Response with Respect to Cure
January 25, 2012, Patient Power
The DASISION chronic myeloid leukaemia trial – ASH2010
February 18, 2011, ecancer.tv
Do 3rd Generation Medicines Lie Ahead for CML?
December 4, 2010, Patient Power , ASH 2010, Orlando
ARTICLES
Comorbidities Can Affect CML Treatment Decisions
July 25, 2019, Oncology Nursing News
TKI Discontinuation Criteria Established in Updated NCCN CML Guideline
March 23, 2019, OncLive
Emerging Agents, TKI Discontinuation Focal Points of CML Research
October 29, 2018, OncLive
Comorbidities Can Affect CML Treatment Decisions
July 25, 2019, Oncology Nursing News
TKI Discontinuation Criteria Established in Updated NCCN CML Guideline
March 23, 2019, OncLive
Emerging Agents, TKI Discontinuation Focal Points of CML Research
October 29, 2018, OncLive
